المؤلفون: Xu W; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Qiu L; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Li F; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Fei Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Wei Q; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Shi K; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Zhu Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Luo J; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Wu M; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Yuan J; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Liu H; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Mao J; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Cao Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. Electronic address: yuandongcao@163.com., Zhou S; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. Electronic address: zhoushu164086035@126.com., Guan X; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China. Electronic address: guanxin@cpu.edu.cn.

المصدر: Oral oncology [Oral Oncol] 2024 Jul; Vol. 154, pp. 106865. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis* , Nasopharyngeal Carcinoma*/drug therapy , Nasopharyngeal Carcinoma*/economics , Nasopharyngeal Carcinoma*/mortality , Induction Chemotherapy*/economics , Induction Chemotherapy*/methods , Network Meta-Analysis* , Nasopharyngeal Neoplasms*/drug therapy , Nasopharyngeal Neoplasms*/economics, Humans ; Quality-Adjusted Life Years ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/economics ; Cost-Effectiveness Analysis

المؤلفون: Yao Y; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Ouyang Q; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Wang S; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Li K; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Luo Q; Department of Otorhinolaryngology, Head and Neck Surgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Qiu L; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Liu F; Department of Gerontology, Jiangxi Provincial People's Hospital, Nanchang 330006, China., Tan L; Ganzhou Cancer Hospital, Ganzhou 341000, China., Li Q; Heyuan People's Hospital, Heyuan, Guangdong Province 517000, China., Ren B; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China., Long P; Department of Otorhinolaryngology, Head and Neck Surgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China. Electronic address: yifuyuanlongping@163.com., Ye J; Department of Otorhinolaryngology, Head and Neck Surgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China. Electronic address: yjholly@ncu.edu.cn., Zhong X; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China. Electronic address: zhongxiaojun@ncu.edu.cn.

المصدر: Oral oncology [Oral Oncol] 2024 Jul; Vol. 154, pp. 106867. Date of Electronic Publication: 2024 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Induction Chemotherapy*/methods , Nasopharyngeal Carcinoma*/drug therapy , Nasopharyngeal Carcinoma*/therapy , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Nasopharyngeal Neoplasms*/drug therapy , Nasopharyngeal Neoplasms*/therapy , Nasopharyngeal Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Immune Checkpoint Inhibitors/therapeutic use ; Treatment Outcome ; Young Adult

المؤلفون: von Deimling M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mertens LS; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Furrer M; Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland.; Department of Urology, Solothurner Spitäler AG, Kantonsspital Olten and Bürgerspital Solothurn, Switzerland., Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Tendijck GAH; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Taylor J; Department of Urology, University of Texas Southwestern, Dallas, TX, USA., Crocetto F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy., Maas M; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy., Pichler R; Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria., Moschini M; Department of Urology, Urological Research Institute, Vita-Salute San Raffaele, Milan, Italy., Tully KH; Department of Urology and Neurourology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany., D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Del Giudice F; Department of Maternal Infant and Urologic Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, Rome, Italy., Marcq G; Department of Urology, CHU Lille, Claude Huriez Hospital, Lille, France.; CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, University of Lille, Lille, France., Velev M; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Gallioli A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Albisinni S; Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy.; Service d'Urologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Khanna A; Department of Urology, Mayo Clinic, Rochester, MN, USA., Rink M; Department of Urology, Marienkrankenhaus, Hamburg, Germany., Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Minervini A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Lotan Y; Department of Urology, University of Texas Southwestern, Dallas, TX, USA., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kiss B; Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Urosud, La Croix Du Sud Hospital, Quint-Fonsegrives, France.

مؤلفون مشاركون: CLIPOLY Study Group Collaborators

المصدر: BJU international [BJU Int] 2024 Jul; Vol. 134 (1), pp. 119-127. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/mortality , Induction Chemotherapy* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Cystectomy*/methods , Lymphatic Metastasis*, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Treatment Outcome ; Gemcitabine ; Cisplatin/administration & dosage ; Lymph Node Excision ; Methotrexate/administration & dosage ; Lymph Nodes/pathology ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/administration & dosage

المؤلفون: Hou LM; Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China., Gao Y; Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.E-mail: yingg7727@163.com., Gao QY; Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China., Niu B; Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.

المصدر: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Jun; Vol. 32 (3), pp. 679-684.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Decitabine*/administration & dosage , Induction Chemotherapy* , Leukemia, Myeloid, Acute*/drug therapy, Humans ; Retrospective Studies ; T-Lymphocytes, Regulatory ; Quality of Life ; Male ; Female ; Treatment Outcome ; Survival Rate

المؤلفون: Chen Z; Department of Radiology, the First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570102, China; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China. Electronic address: zhiqiang_chen99@163.com., Wang Z; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China., Liu S; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China., Zhang S; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China., Zhou Y; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China., Zhang R; Department of Radiology, the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China., Yang W; Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan 571199, China. Electronic address: ywj007@yeah.net.

المصدر: European journal of radiology [Eur J Radiol] 2024 Jun; Vol. 175, pp. 111438. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Nomograms* , Nasopharyngeal Carcinoma*/diagnostic imaging , Nasopharyngeal Carcinoma*/drug therapy , Multiparametric Magnetic Resonance Imaging*/methods , Nasopharyngeal Neoplasms*/diagnostic imaging , Nasopharyngeal Neoplasms*/drug therapy , Induction Chemotherapy*, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Treatment Outcome ; Aged ; Young Adult ; Radiomics

المؤلفون: Dong A; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Zhu S; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Ma H; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Wei X; Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China., Huang W; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Ruan G; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Liu L; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Mo Y; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China., Ai F; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China.

المصدر: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Jun; Vol. 59 (6), pp. 1976-1990. Date of Electronic Publication: 2023 Sep 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Magnetic Resonance Imaging*/methods , Nasopharyngeal Carcinoma*/diagnostic imaging , Nasopharyngeal Carcinoma*/drug therapy , Nasopharyngeal Carcinoma*/pathology , Induction Chemotherapy* , Nasopharyngeal Neoplasms*/diagnostic imaging , Nasopharyngeal Neoplasms*/drug therapy , Lymph Nodes*/diagnostic imaging , Lymph Nodes*/pathology, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Prognosis ; Adult ; Aged ; Lymphatic Metastasis/diagnostic imaging ; Reproducibility of Results ; Young Adult ; Adolescent

المؤلفون: Jin YN; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, 519000, China., Qiang MY; Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang Province, 310022, China., Wang Y; Department of Nuclear Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, 519000, China., Lin YJ; Department of Pathology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, 519001, China., Jiang RW; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, 519000, China., Cao WW; Department of Pathology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, 519001, China., Zhang WJ; Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China., Wang SY; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, 519000, China., Zhang HY; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, 519000, China. zhhyu@mail.sysu.edu.cn., Yao JJ; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong Province, 519000, China. yaojj23@mail.sysu.edu.cn.; The Cancer Center of Nasopharyngeal Carcinoma, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, 519000, China. yaojj23@mail.sysu.edu.cn.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 May 11; Vol. 73 (7), pp. 125. Date of Electronic Publication: 2024 May 11.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/therapy , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/drug therapy , Chemoradiotherapy*/methods , Propensity Score* , Nasopharyngeal Neoplasms*/therapy , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/drug therapy , Induction Chemotherapy*/methods, Humans ; Male ; Female ; Middle Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Immune Checkpoint Inhibitors/therapeutic use ; Aged ; Cisplatin/therapeutic use ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Deoxycytidine/administration & dosage ; Retrospective Studies ; Gemcitabine

المؤلفون: Franco S; Department of Internal Medicine, Northwestern Medicine, Chicago, IL, USA., Khan T; Robert H. Lurie Comprehensive Cancer Center, Department of Pharmacy, Chicago, IL, USA., Dinner S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Karmali R; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Melody M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 945-949. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Obesity, Morbid* , Leukemia, Myeloid, Acute*/drug therapy , Induction Chemotherapy*/methods , Cytarabine*/administration & dosage , Daunorubicin*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Adult ; Nucleophosmin ; Body Mass Index

المؤلفون: Zeng C; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Yang Q; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Neurosurgery., Li Z; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Wei Z; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Chen T; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Deng M; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Wang J; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Neurosurgery., Wang J; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Sun F; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Huang J; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Lu S; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Zhu J; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology., Sun X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology. Electronic address: sunxf@sysucc.org.cn., Zhen Z; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Pediatric Oncology. Electronic address: zhenzj@sysucc.org.cn.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jul 01; Vol. 119 (3), pp. 858-868. Date of Electronic Publication: 2023 Dec 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Germ Cell and Embryonal*/radiotherapy , Neoplasms, Germ Cell and Embryonal*/mortality , Neoplasms, Germ Cell and Embryonal*/pathology , Induction Chemotherapy* , Central Nervous System Neoplasms*/radiotherapy , Central Nervous System Neoplasms*/mortality , Central Nervous System Neoplasms*/pathology, Humans ; Adolescent ; Child ; Male ; Prospective Studies ; Child, Preschool ; Treatment Outcome ; Female ; Craniospinal Irradiation/methods ; Radiotherapy Dosage ; Testicular Neoplasms/radiotherapy ; Testicular Neoplasms/pathology ; Testicular Neoplasms/mortality ; Progression-Free Survival

SCR Disease Name: Nonseminomatous germ cell tumor

المؤلفون: Herzi D; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Le Garff-Tavernier M; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Sourdeau E; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Choquet S; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Soussain C; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Nichelli L; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Mathon B; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Mokhtari K; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Laurenge A; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Alentorn A; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Boussen I; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Alcantara M; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Hoang-Xuan K; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France., Houillier C; From the Departments of Neurooncology (D.H., A.L., A.A., K.H.-X., C.H.), Biological Hematology (M.L.G.-T., E.S.), Clinical Hematology (S.C., I.B.), Neuro-radiology (L.N.), Neurosurgery (B.M.), and Neuropathology (K.M.), Hôpital Pitié-Salpêtrière, Paris; and Clinical Hematology (C.S., M.A.) Institut Curie, Saint Cloud, France.

المصدر: Neurology [Neurology] 2024 Jun 25; Vol. 102 (12), pp. e209527. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-10*/cerebrospinal fluid , Central Nervous System Neoplasms*/cerebrospinal fluid , Central Nervous System Neoplasms*/drug therapy , Induction Chemotherapy*, Humans ; Middle Aged ; Female ; Male ; Aged ; Retrospective Studies ; Prognosis ; Adult ; Lymphoma/cerebrospinal fluid ; Lymphoma/drug therapy ; Methotrexate/therapeutic use ; Methotrexate/administration & dosage